JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A5707 PD318088

Target: MEK

Summary: Allosteric MEK1/2 inhibitor, non-ATP competitive

≥28.05 mg/mL
A8386 Busulfan

3 Citation

Summary: DNA alkylating agent

≥12.3 mg/mL
A8631 FK 866 HCL

Target: NMPRTase

Summary: NMPRTase inhibitor

≥18.95 mg/mL
A8691 Flumatinib mesylate

Summary: PDGRFβ inhibitor

Soluble in DMSO
A9904 AKT/mTOR Set I

Summary: For inhibiting AKT/mTOR
B1431 (E/Z)-TG003

Target: Cdc2-like kinase (Clk)

Summary: Cdc2-like kinase (Clk) inhibitor

insoluble in H2O; ≥12.45 mg/mL
B1637 OSI-027

Summary: MTORC1/ mTORC2 inhibitor

insoluble in EtOH; insoluble in H2O; ≥32.5 mg/mL
B1406 SB590885

1 Citation

Summary: Potent B-Raf inhibitor

insoluble in H2O; insoluble in EtOH; ≥4.54 mg/mL
B1401 Cabozantinib malate (XL184)

Summary: MET andVEGF receptor2 inhibitor

≥31.8 mg/mL
C5813 CFI-400945

Summary: orally available, selective inhibitor of polo-like kinase 4 (PLK4)

insoluble in H2O; ≥109.8 mg/mL